Brief: Ionis Announces Proposed Convertible Offering To Refinance 2026 Convertible Notes
11/11/2025 21:06
Nov 12 (Reuters) - Ionis Pharmaceuticals Inc IONS.O: IONIS ANNOUNCES PROPOSED CONVERTIBLE OFFERING TO REFINANCE 2026 CONVERTIBLE NOTES IONIS PHARMACEUTICALS INC - TO OFFER $700 MILLION CONVERTIBLE NOTES DUE 2030 IONIS PHARMACEUTICALS INC - GRANTS OPTION FOR ADDITIONAL $70 MILLION NOTES Source text: ID:nBwbFdtbka Further company coverage: IONS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ionis Pharmaceuticals
See all newsUS FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment (updated)
US FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment
Focus: AI companies run virtual drug trials, aim to improve success of human studies
Brief: Ionis Pharmaceuticals Says Ulefnersen Demonstrates Favorable Safety And Tolerability Profile
Otsuka, Ionis' experimental ALS drug meets main goal in late-stage study